5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer
The goal of this study is to evaluate 5 days vs. 9 days of whole breast radiation.
Breast Cancer|Invasive Carcinoma of Breast|Ductal Breast Carcinoma in Situ
RADIATION: Radiation Therapy
24-month Mean breast overall satisfaction Breast - Q scores with 5 fractions of radiation is non-inferior in patient reported outcomes., To evaluate non-inferiority of 24-month Breast-Q satisfaction with breast score with 5 versus 9 fractions of radiation., 3 years
Evaluate acute and late radiation-related adverse events (AEs) and serious adverse events (SAEs) between the two arms, characterized by type, To estimate the incidence of acute and late radiation complications between the two arms, based on CTCAE 5.0 toxicity., 5 years|Evaluate acute and late radiation-related adverse events (AEs) and serious adverse events (SAEs) between the two arms, characterized by severity (as defined by the NIH CTCAE, version 5.0), To estimate the incidence of acute and late radiation complications between the two arms, based on CTCAE 5.0 toxicity., 5 years|Evaluate acute and late radiation-related adverse events (AEs) and serious adverse events (SAEs) between the two arms, characterized by seriousness, To estimate the incidence of acute and late radiation complications between the two arms, based on CTCAE 5.0 toxicity., 5 years|Evaluate acute and late radiation-related adverse events (AEs) and serious adverse events (SAEs) between the two arms, characterized by duration, To estimate the incidence of acute and late radiation complications between the two arms, based on CTCAE 5.0 toxicity., 5 years|Evaluate acute and late radiation-related adverse events (AEs) and serious adverse events (SAEs) between the two arms, characterized by relationship to study treatment., To estimate the incidence of acute and late radiation complications between the two arms, based on CTCAE 5.0 toxicity., 5 years|Evaluate non-inferiority of local and local regional recurrence rate in the treatment arms., To evaluate non-inferiority of the local and local regional recurrence rate between the two arms., 8 years|Evaluate non-inferiority of a change in cosmetic scores in the treatment arms with pre-radiation scores to post 24-month scores using the UK photographic assessment and EORTC scales., To evaluate non-inferiority of the breast photographic cosmetic outcomes of the UK and EORTC scales, 5 years
The goal of this study is to evaluate 5 days vs. 9 days of whole breast radiation.